Group One Trading, L.P. Brainstorm Cell Therapeutics Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 46,754 shares of BCLI stock, worth $81,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,754

Previous 46,754 -0.0%

Holding current value

$81,819

Previous $15,000 33.33%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.34 - $0.74 $5,474 - $11,914	16,100 Added 52.52%	46,754 $15,000
Q1 2024 May 10, 2024	BUY	$0.28 - $0.66 $1,851 - $4,363	6,611 Added 27.5%	30,654 $17,000
Q4 2023 Feb 14, 2024	SELL	$0.15 - $0.4 $10,956 - $29,218	-73,045 Reduced 75.24%	24,043 $6,000
Q3 2023 Nov 09, 2023	BUY	$0.2 - $2.08 $19,417 - $201,943	97,088 New	97,088 $19,000
Q1 2023 May 12, 2023	BUY	$1.43 - $3.3 $208,458 - $481,057	145,775 Added 858.61%	162,753 $537,000
Q4 2022 Feb 09, 2023	BUY	$1.37 - $4.42 $23,259 - $75,042	16,978 New	16,978 $27,000
Q2 2022 Aug 11, 2022	SELL	$2.71 - $3.6 $67,649 - $89,866	-24,963 Reduced 50.84%	24,134 $67,000
Q1 2022 May 12, 2022	BUY	$2.92 - $4.19 $143,363 - $205,716	49,097 New	49,097 $165,000
Q2 2021 Aug 10, 2021	SELL	$3.01 - $4.01 $200,201 - $266,713	-66,512 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$3.46 - $7.88 $128,801 - $293,340	-37,226 Reduced 35.88%	66,512 $255,000
Q4 2020 Feb 10, 2021	BUY	$3.99 - $17.73 $413,914 - $1.84 Million	103,738 New	103,738 $469,000
Q1 2020 May 13, 2020	SELL	$4.01 - $8.88 $180,686 - $400,123	-45,059 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$3.62 - $4.29 $294,668 - $349,206	-81,400 Reduced 64.37%	45,059 $193,000
Q3 2019 Nov 12, 2019	BUY	$3.54 - $4.48 $53,857 - $68,158	15,214 Added 13.68%	126,459 $493,000
Q2 2019 Aug 09, 2019	BUY	$3.59 - $4.3 $231,274 - $277,014	64,422 Added 137.59%	111,245 $439,000
Q1 2019 May 13, 2019	BUY	$3.37 - $4.34 $123,867 - $159,521	36,756 Added 365.11%	46,823 $203,000
Q4 2018 Feb 06, 2019	BUY	$2.98 - $3.9 $29,999 - $39,261	10,067 New	10,067 $36,000
Q3 2017 Nov 15, 2017	SELL	$3.98 - $4.36 $2,388 - $2,616	-600 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	600	600 $3,000

Others Institutions Holding BCLI

# of Institutions

Shares Held

8.63M

Call Options Held

160K

Put Options Held

30.5K

View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $63.9M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

More about BCLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Brainstorm Cell Therapeutics Inc. Transaction History